CPLM 1.0 - Compendium of Protein Lysine ModificationTag | Content |
---|
CPLM ID | CPLM-037337 | UniProt Accession | | Genbank Protein ID | | Genbank Nucleotide ID | | Protein Name | DNA topoisomerase 2 | Protein Synonyms/Alias | | Gene Name | TOP2B | Gene Synonyms/Alias | | Created Date | July 27, 2013 | Organism | Homo sapiens (Human) | NCBI Taxa ID | 9606 | Lysine Modification | Position | Peptide | Type | References |
---|
3 | *****MAKSGGCGAG | ubiquitination | [1] | 29 | WVNNAAKKEESETAN | ubiquitination | [1] | 37 | EESETANKNDSSKKL | ubiquitination | [2] | 112 | LVNAADNKQRDKNMT | ubiquitination | [1, 2, 3, 4, 5] | 116 | ADNKQRDKNMTCIKV | ubiquitination | [1] | 139 | ISIWNNGKGIPVVEH | ubiquitination | [1, 2] | 147 | GIPVVEHKVEKVYVP | ubiquitination | [1, 2, 3, 6] | 150 | VVEHKVEKVYVPALI | ubiquitination | [1, 6] | 172 | SNYDDDEKKVTGGRN | ubiquitination | [1, 5] | 173 | NYDDDEKKVTGGRNG | ubiquitination | [1] | 184 | GRNGYGAKLCNIFST | ubiquitination | [1, 6] | 200 | FTVETACKEYKHSFK | ubiquitination | [1] | 216 | TWMNNMMKTSEAKIK | ubiquitination | [1] | 223 | KTSEAKIKHFDGEDY | ubiquitination | [1] | 249 | FKMEKLDKDIVALMT | ubiquitination | [5, 7] | 270 | AGSCRGVKVMFNGKK | acetylation | [6, 8] | 277 | KVMFNGKKLPVNGFR | ubiquitination | [1] | 292 | SYVDLYVKDKLDETG | ubiquitination | [1] | 294 | VDLYVKDKLDETGVA | ubiquitination | [1, 2] | 303 | DETGVALKVIHELAN | ubiquitination | [1, 2, 3] | 337 | VNSIATTKGGRHVDY | ubiquitination | [1, 6, 7] | 352 | VVDQVVGKLIEVVKK | ubiquitination | [1] | 360 | LIEVVKKKNKAGVSV | ubiquitination | [1] | 362 | EVVKKKNKAGVSVKP | ubiquitination | [1, 2] | 368 | NKAGVSVKPFQVKNH | acetylation | [6] | 368 | NKAGVSVKPFQVKNH | ubiquitination | [1, 6] | 402 | ENMTLQPKSFGSKCQ | ubiquitination | [1, 7] | 407 | QPKSFGSKCQLSEKF | ubiquitination | [1, 3, 4, 6] | 413 | SKCQLSEKFFKAASN | ubiquitination | [1] | 434 | ILNWVKFKAQTQLNK | ubiquitination | [1] | 447 | NKKCSSVKYSKIKGI | acetylation | [6] | 466 | DANDAGGKHSLECTL | ubiquitination | [1] | 482 | LTEGDSAKSLAVSGL | ubiquitination | [1, 3] | 505 | GVFPLRGKILNVREA | ubiquitination | [1, 6, 7] | 515 | NVREASHKQIMENAE | ubiquitination | [1, 2, 3, 4, 5, 6, 7] | 535 | KIVGLQYKKSYDDAE | ubiquitination | [1, 4] | 536 | IVGLQYKKSYDDAES | ubiquitination | [1, 2, 6, 7] | 545 | YDDAESLKTLRYGKI | ubiquitination | [1, 2, 3, 5, 6, 7] | 551 | LKTLRYGKIMIMTDQ | ubiquitination | [1, 2, 5, 7] | 595 | EFITPIVKASKNKQE | ubiquitination | [1, 2, 5] | 600 | IVKASKNKQELSFYS | ubiquitination | [1, 2, 4, 5, 6] | 615 | IPEFDEWKKHIENQK | ubiquitination | [1, 2] | 622 | KKHIENQKAWKIKYY | ubiquitination | [1, 2, 3] | 630 | AWKIKYYKGLGTSTA | ubiquitination | [1, 2, 6] | 638 | GLGTSTAKEAKEYFA | ubiquitination | [1, 2, 6] | 641 | TSTAKEAKEYFADME | ubiquitination | [1, 2, 5, 6] | 671 | AITLAFSKKKIDDRK | ubiquitination | [1, 2, 3, 4, 5] | 672 | ITLAFSKKKIDDRKE | ubiquitination | [1, 6] | 678 | KKKIDDRKEWLTNFM | ubiquitination | [1, 2, 6, 7] | 707 | FLYGTATKHLTYNDF | ubiquitination | [1, 2, 3, 5] | 739 | PSLVDGFKPGQRKVL | ubiquitination | [1, 6, 7] | 744 | GFKPGQRKVLFTCFK | ubiquitination | [1] | 751 | KVLFTCFKRNDKREV | ubiquitination | [1] | 912 | LPNYKNFKGTIQELG | ubiquitination | [1] | 965 | PMLNGTDKTPALISD | ubiquitination | [2] | 974 | PALISDYKEYHTDTT | ubiquitination | [2] | 983 | YHTDTTVKFVVKMTE | ubiquitination | [7] | 987 | TTVKFVVKMTEEKLA | acetylation | [8] | 987 | TTVKFVVKMTEEKLA | ubiquitination | [1] | 1003 | AEAAGLHKVFKLQTT | ubiquitination | [7] | 1063 | MLGAESTKLNNQARF | ubiquitination | [2] | 1074 | QARFILEKIQGKITI | ubiquitination | [1, 6] | 1078 | ILEKIQGKITIENRS | ubiquitination | [1] | 1086 | ITIENRSKKDLIQML | ubiquitination | [1] | 1104 | GYESDPVKAWKEAQE | ubiquitination | [1] |
| Reference | [1] Refined preparation and use of anti-diglycine remnant (K-ε-GG) antibody enables routine quantification of 10,000s of ubiquitination sites in single proteomics experiments. Udeshi ND, Svinkina T, Mertins P, Kuhn E, Mani DR, Qiao JW, Carr SA. Mol Cell Proteomics. 2013 Mar;12(3):825-31. [ PMID: 23266961] [2] Systematic and quantitative assessment of the ubiquitin-modified proteome. Kim W, Bennett EJ, Huttlin EL, Guo A, Li J, Possemato A, Sowa ME, Rad R, Rush J, Comb MJ, Harper JW, Gygi SP. Mol Cell. 2011 Oct 21;44(2):325-40. [ PMID: 21906983] [3] Global identification of modular cullin-RING ligase substrates. Emanuele MJ, Elia AE, Xu Q, Thoma CR, Izhar L, Leng Y, Guo A, Chen YN, Rush J, Hsu PW, Yen HC, Elledge SJ. Cell. 2011 Oct 14;147(2):459-74. [ PMID: 21963094] [4] Methods for quantification of in vivo changes in protein ubiquitination following proteasome and deubiquitinase inhibition. Udeshi ND, Mani DR, Eisenhaure T, Mertins P, Jaffe JD, Clauser KR, Hacohen N, Carr SA. Mol Cell Proteomics. 2012 May;11(5):148-59. [ PMID: 22505724] [5] Landscape of the PARKIN-dependent ubiquitylome in response to mitochondrial depolarization. Sarraf SA, Raman M, Guarani-Pereira V, Sowa ME, Huttlin EL, Gygi SP, Harper JW. Nature. 2013 Apr 18;496(7445):372-6. [ PMID: 23503661] [6] Integrated proteomic analysis of post-translational modifications by serial enrichment. Mertins P, Qiao JW, Patel J, Udeshi ND, Clauser KR, Mani DR, Burgess MW, Gillette MA, Jaffe JD, Carr SA. Nat Methods. 2013 Jul;10(7):634-7. [ PMID: 23749302] [7] A proteome-wide, quantitative survey of in vivo ubiquitylation sites reveals widespread regulatory roles. Wagner SA, Beli P, Weinert BT, Nielsen ML, Cox J, Mann M, Choudhary C. Mol Cell Proteomics. 2011 Oct;10(10):M111.013284. [ PMID: 21890473] [8] Proteomic investigations of lysine acetylation identify diverse substrates of mitochondrial deacetylase sirt3. Sol EM, Wagner SA, Weinert BT, Kumar A, Kim HS, Deng CX, Choudhary C. PLoS One. 2012;7(12):e50545. [ PMID: 23236377] | Functional Description | Control of topological states of DNA by transient breakage and subsequent rejoining of DNA strands. Topoisomerase II makes double-strand breaks (By similarity). | Sequence Annotation | | Keyword | ATP-binding; Complete proteome; DNA-binding; Isomerase; Nucleotide-binding; Reference proteome; Topoisomerase. | Sequence Source | UniProt (SWISSPROT/TrEMBL); GenBank; EMBL | Protein Length | 1150 AA | Protein Sequence | MAKSGGCGAG AGVGGGNGAL TWVNNAAKKE ESETANKNDS SKKLSVERVY QKKTQLEHIL 60 LRPDTYIGSV EPLTQFMWVY DEDVGMNCRE VTFVPGLYKI FDEILVNAAD NKQRDKNMTC 120 IKVSIDPESN IISIWNNGKG IPVVEHKVEK VYVPALIFGQ LLTSSNYDDD EKKVTGGRNG 180 YGAKLCNIFS TKFTVETACK EYKHSFKQTW MNNMMKTSEA KIKHFDGEDY TCITFQPDLS 240 KFKMEKLDKD IVALMTRRAY DLAGSCRGVK VMFNGKKLPV NGFRSYVDLY VKDKLDETGV 300 ALKVIHELAN ERWDVCLTLS EKGFQQISFV NSIATTKGGR HVDYVVDQVV GKLIEVVKKK 360 NKAGVSVKPF QVKNHIWVFI NCLIENPTFD SQTKENMTLQ PKSFGSKCQL SEKFFKAASN 420 CGIVESILNW VKFKAQTQLN KKCSSVKYSK IKGIPKLDDA NDAGGKHSLE CTLILTEGDS 480 AKSLAVSGLG VIGRDRYGVF PLRGKILNVR EASHKQIMEN AEINNIIKIV GLQYKKSYDD 540 AESLKTLRYG KIMIMTDQDQ DGSHIKGLLI NFIHHNWPSL LKHGFLEEFI TPIVKASKNK 600 QELSFYSIPE FDEWKKHIEN QKAWKIKYYK GLGTSTAKEA KEYFADMERH RILFRYAGPE 660 DDAAITLAFS KKKIDDRKEW LTNFMEDRRQ RRLHGLPEQF LYGTATKHLT YNDFINKELI 720 LFSNSDNERS IPSLVDGFKP GQRKVLFTCF KRNDKREVKV AQLAGSVAEM SAYHHGEQAL 780 MMTIVNLAQN FVGSNNINLL QPIGQFGTRL HGGKDAASPR YIFTMLSTLA RLLFPAVDDN 840 LLKFLYDDNQ RVEPEWYIPI IPMVLINGAE GIGTGWACKL PNYDAREIVN NVRRMLDGLD 900 PHPMLPNYKN FKGTIQELGQ NQYAVSGEIF VVDRNTVEIT ELPVRTWTQV YKEQVLEPML 960 NGTDKTPALI SDYKEYHTDT TVKFVVKMTE EKLAQAEAAG LHKVFKLQTT LTCNSMVLFD 1020 HMGCLKKYET VQDILKEFFD LRLSYYGLRK EWLVGMLGAE STKLNNQARF ILEKIQGKIT 1080 IENRSKKDLI QMLVQRGYES DPVKAWKEAQ EKAAEEDETQ NQHDDSSSDS GTPSGPDFNY 1140 ILNMSLWSLT 1150 | Gene Ontology | | Interpro | | Pfam | | SMART | | PROSITE | | PRINTS | |
|